India's healthcare sector has seen a major transformation over the last 12 years. Health insurance coverage has expanded significantly. Mat...

The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...

The latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

If the US-Iran ceasefire holds, the markets may see some recovery. The movement of crude oil prices and its impact on the markets supports ...

Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Nayana Vaidya built Om Sai Surgicals from a modest beginning. Her company achieved a turnover of nearly ₹48 crore. Vaidya finds satisfactio...

Happy Thursday! Mid-sized IT firms are realigning leadership teams as AI-driven changes force a rethink. This and more in today's ETtech Mo...

The CDSCO has advised state drug controllers to prevent drug scarcity during the AIOCD's proposed e-pharmacy strike on May 20. Measures inc...

Over 20,000 chemists in Karnataka will shut down their stores on May 20. This is part of a nationwide protest against online pharmacies. Th...

Pharmacies nationwide will stay open on May 20. This defies a strike called by the All India Organisation of Chemists and Druggists against...

India's drug regulator is actively reviewing concerns from retail chemists about e-pharmacies. The All India Organisation of Chemists and D...

As nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...

Can the NPS Swasthya scheme be an effective substitute for a comprehensive health insurance plan that covers hospitalisation and related ex...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

If you are putting fresh money into the market, it might be a good idea to stay with companies that don't have much to do with global suppl...